Several studies demonstrated the potential of FGF-23 as a marker of mortality in dialysis patients[29], initiation of chronic dialysis[30], CKD progression[31,32], cardiovascular disease[30], cardiovascular mortality[32] or all-cause mortality[30,32]. This evidence concerns the gene FGF23 and chronic kidney disease.